ARYX (ARYx Therapeutics) Total Liabilities: $13.71 Mil (As of Sep. 2010)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ARYx Therapeutics Total Liabilities?

ARYx Therapeutics ARYX -99.80% Total Liabilities is $13.71 Mil as of Sep. 2010.

ARYx Therapeutics's Total Liabilities for the quarter that ended in Sep. 2010 was $13.71 Mil.

ARYx Therapeutics's quarterly Total Liabilities declined from Mar. 2010 ($12.98 Mil) to Jun. 2010 ($10.95 Mil) but then increased from Jun. 2010 ($10.95 Mil) to Sep. 2010 ($13.71 Mil).

ARYx Therapeutics's annual Total Liabilities declined from Dec. 2007 ($34.28 Mil) to Dec. 2008 ($23.73 Mil) and declined from Dec. 2008 ($23.73 Mil) to Dec. 2009 ($15.32 Mil).

ARYx Therapeutics Total Liabilities Historical Data

* Premium members only.

The historical data trend for ARYx Therapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYx Therapeutics Total Liabilities Chart

ARYx Therapeutics Annual Data
Trend Dec03 Dec04 Dec05 Dec06 Dec07 Dec08 Dec09
Total Liabilities
Get a 7-Day Free Trial 100.40 150.48 34.28 23.73 15.32

ARYx Therapeutics Quarterly Data
Dec05 Mar06 Jun06 Sep06 Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 17.47 15.32 12.98 10.95 13.71

ARYx Therapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

ARYx Therapeutics's Total Liabilities for the fiscal year that ended in Dec. 2009 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=8.681+(6.641+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=15.32

Total Liabilities=Total Assets (A: Dec. 2009 )-Total Equity (A: Dec. 2009 )
=12.406--2.916
=15.32

ARYx Therapeutics's Total Liabilities for the quarter that ended in Sep. 2010 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=7.789+(5.495+0.423
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=13.71

Total Liabilities=Total Assets (Q: Sep. 2010 )-Total Equity (Q: Sep. 2010 )
=5.972--7.735
=13.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $13.71 Mil mean?
ARYx Therapeutics (ARYX) has a Total Liabilities of $13.71 Mil as of Sep. 2010. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ARYx Therapeutics and its competitors.
Is ARYx Therapeutics' Total Liabilities too high?
ARYx Therapeutics' current Total Liabilities is $13.71 Mil.
How does ARYx Therapeutics' Total Liabilities compare to YBAO and HPMM?
ARYx Therapeutics' Total Liabilities of $13.71 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Drug Manufacturers company?
A good Total Liabilities depends on the Drug Manufacturers industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for ARYx Therapeutics and its competitors. ARYx Therapeutics's current Total Liabilities is $13.71 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ARYx Therapeutics stock overvalued right now?
ARYx Therapeutics (ARYX) has a current Total Liabilities of $13.71 Mil. The current Total Liabilities is $13.71 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For ARYx Therapeutics (ARYX), the current Total Liabilities is $13.71 Mil as of Sep. 2010. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ARYx Therapeutics Business Description

Address 6300 Dumbarton Circle, Fremont, CA, USA, 94555
ARYx Therapeutics Inc is a biopharmaceutical company focused on developing a portfolio of internally discovered product candidates designed to eliminate known safety issues associated with well-established, commercially successful drugs.